Latest Clostridium Stories
Data Demonstrate Potency and Selectivity of Targetable, Highly Precise Antibacterials with Applications in Bacterial Disease and Microbiome Research SOUTH SAN FRANCISCO, Calif., March
Jvion, the leader in clinical predictive algorithms, announced the development of a Clostridium Difficile (C Diff) use case to help clinicians reduce the risk of deadly infections inside and outside
DALLAS, February 3, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Botulism - Pipeline Review, H1 2015" market research report to its store.
Banatrol Plus is now available in Pineapple Banana - a tasty way to fight diarrhea.
As Public Health Preoccupies Americans, Foundation that Fights Deadly Infections Honored Leaders for Significant Contributions to Clostridium Difficile Treatment, Research and Patient Advocacy
ROCKVILLE, Md., Sept.
A fast-sensitive "electronic-nose" for sniffing the highly infectious bacteria C. diff, that causes diarrhoea, temperature and stomach cramps, has been developed by a team at the University of Leicester.
-- Company Completes Final Preclinical Toxicology Study and Prepares to File Investigational New Drug (IND) in 2H 2014 -- ROCKVILLE, Md., Sept.
ROCKVILLE, Md., Aug.
Company launches video to help raise awareness of the brand's history and impact on patients IRVINE, Calif., May 8, 2014 /PRNewswire/ -- Allergan, Inc.
Clostridium botulinum is a gram-positive, rod-shaped bacterium that produces neurotoxins, known as botulinum neurotoxins types A-G, that cause the flaccid muscular paralysis seen in botulism. It is the main paralytic agent in botox and is commonly found in soil. It is also an obligate anaerobe, meaning oxygen is poisonous to the cells. Superoxide dismutase helps C. botulinum tolerate traces of oxygen. It was first recognized and isolated in 1895 by Emile van Ermengem. Subsequent outbreaks...
- Large; stout; burly.